Bristol-Myers Squibb (BMY) Fails to deliver data

Key failure to deliver metrics for Bristol-Myers Squibb:

• Last SEC data release: 2026-03-31
• Last 15 days FTD volume: NZ$0.08 M
• Last 3 months FTD volume: NZ$20.35 M
• Last 12 months FTD volume: NZ$70.85 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Bristol-Myers Squibb (BMY) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Bristol-Myers Squibb (BMY) - since 2013

Bristol-Myers Squibb (BMY) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Johnson & Johnson JNJ	NZ$78.35 M	NZ$0.16 B	🇺🇸 USA
Novartis NVS	NZ$0.27 B	NZ$0.36 B	🇨🇭 Switzerland
Pfizer PFE	NZ$23.8 M	NZ$0.12 B	🇺🇸 USA
AbbVie ABBV	NZ$0.19 B	NZ$0.25 B	🇺🇸 USA
Eli Lilly LLY	NZ$33.38 M	NZ$0.40 B	🇺🇸 USA
Amgen AMGN	NZ$0.33 B	NZ$0.42 B	🇺🇸 USA
Sanofi SNY	NZ$1.71 M	NZ$64.59 M	🇫🇷 France
Biogen BIIB	NZ$2.17 M	NZ$56.59 M	🇺🇸 USA
Merck MRK	NZ$0.11 B	NZ$0.19 B	🇺🇸 USA
AstraZeneca AZN	NZ$45.44 M	NZ$0.17 B	🇬🇧 UK